Reduction of carbon tetrachloride-induced rat liver injury by IRFI 042, a novel dual vitamin E-like antioxidant

Carbon tetrachloride (CCl4)-induced hepatotoxicity is likely the result of a CCl4-induced free radical production which causes membrane lipid peroxida tion and activation of transcription factors regulating both the TNF-alpha gene and the early-immediate genes involved in tissue regeneration. IRFI 04 2 is a novel vitamin E-like compound having a masked sulphydryl group in th e aliphatic side chain. We studied the effect of IRFI 042 on CCl4-induced l iver injury. Liver damage was induced in male rats by an intraperitoneal in jection of CCl4 (1 ml/kg in vegetal oil). Serum alanine aminotransferase (A LT) activity, liver malondialdehyde (MAL), hydroxyl radical formation (OH), calculated indirectly by a trapping agent, hepatic reduced glutathione (GS H) concentration, plasma TNF-alpha, liver histology and hepatic mRNA levels for TNF-alpha were evaluated 48 h after CCl4 administration. Hepatic vitam in E (VE) levels were evaluated, in a separate group of animals, 2 h after CCl4 injection. A control group with vitamin E (100 mg/kg) was also heated in order to evaluate the differences versus the analogue treated groups. Intraperitoneal injection of carbon tetrachloride produced a marked increas e in serum ALT activity (CCl4 = 404.61 +/- 10.33 U/L; Controls = 28.54 +/- 4.25 U/L), liver MAL (CCl4 = 0.67 +/- 0.16 nmol/mg protein; Controls = 0.13 +/- 0.06 nmol/mg protein), OH. levels assayed as 2,3-DHBA (CCl4 = 8.73 +/- 1.46 muM; Controls = 0.45 +/- 0.15 muM) and 2,5-DHBA (CCl4 = 24.61 +/- 3.3 2 muM; Controls = 2.75 +/- 0.93 CIM), induced a severe depletion of GSH (CC l4 = 3.26 +/- 1.85 mu mol/g protein; Controls = 17.82 +/- 3.13 mu mol/g pro tein) and a marked decrease in VE levels (CCl4 = 5.67 +/- 1.22 nmol/g tissu e; Controls = 13.47 +/- 3.21 nmol/g tissue), caused liver necrosis, increas ed plasma TNF-alpha levels (CCl4 = 57.36 +/- 13.24 IU/ml; Controls = 7.26 /- 2.31 IU/ml) and enhanced hepatic mRNA for TNF-alpha (CCl4 = 19.22 +/- 4. 38 a.u.; Controls = 0.76 +/- 0.36 a.u.). IRFI 042 (100 mg/kg, 30 min after CCl4 injection) blunted liver MAL (0.32 /- 0.17 nmol/mg protein), decreased the serum levels of ALT (128.71 +/- 13. 23 U/L), and restored the hepatic concentrations of VE (9.52 +/- 3.21 nmol/ g tissue), inhibited OH. production (2,3-DHBA = 3.54 +/- 1.31 muM; 2,5-DHBA = 7.37 +/- 2.46 muM), restored the endogenous antioxidant GSH (12.77 +/- 3 .73 mmol/g protein) and improved histology. Furthermore IRFI 042 treatment suppressed plasma TNF-alpha concentrations (31.47 +/- 18.25 IU/ml) and hepa tic TNF-alpha mRNA levels (11.65 +/- 3.21 a.u.). The acute treatment with v itamin E failed to exert any protective effect against CCl4-induced hepatot oxicity.